Verastem | VSTM - Cost Of Sales


Verastem reported $3.05M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
AbbVie USD 4.29B 73M Jun/2026
Alaunos Therapeutics USD 0 18K Sep/2024
AstraZeneca USD 2.52B 2.73B Jun/2026
Curis USD 314K 9.96M Dec/2025
Cytokinetics USD 160K 104.24M Mar/2026
Gilead Sciences USD 1.44B 174M Mar/2026
Incyte USD 104.96M 457K Jun/2026
Laboratory Of America USD 2.7B 97.8M Jun/2026
Novartis USD 3.71B 251M Jun/2026
Pfizer USD 4.09B 498M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
TG Therapeutics USD 41.19M 7.68M Jun/2026
Verastem USD 3.05M 159K Mar/2026